Fractyl Health, Inc.
GUTS
$0.66
-$0.01-0.88%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -1.92% | 37.69% | 9.17% | -21.05% | -25.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.91% | -7.65% | -4.68% | 13.25% | 14.76% |
| Operating Income | 15.91% | 7.64% | 4.62% | -13.46% | -14.93% |
| Income Before Tax | 138.84% | -75.12% | -96.79% | -61.87% | -614.48% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 138.84% | -75.12% | -96.79% | -61.87% | -614.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 138.84% | -75.12% | -96.79% | -61.87% | -614.48% |
| EBIT | 15.91% | 7.64% | 4.62% | -13.46% | -14.93% |
| EBITDA | 16.06% | 7.93% | 5.01% | -13.23% | -13.87% |
| EPS Basic | 111.98% | 39.64% | -46.05% | -58.10% | -185.54% |
| Normalized Basic EPS | 112.93% | 38.58% | -57.82% | -51.31% | -42.65% |
| EPS Diluted | 111.98% | 39.64% | -46.05% | -58.10% | -185.54% |
| Normalized Diluted EPS | 112.93% | 38.58% | -57.82% | -51.31% | -42.65% |
| Average Basic Shares Outstanding | 224.34% | 190.12% | 34.77% | 2.39% | 64.33% |
| Average Diluted Shares Outstanding | 224.34% | 190.12% | 34.77% | 2.39% | 64.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |